Management Team

Sean Hird

Sean Hird

Ph.D

Chief Executive Officer

Sean Hird is the founding CEO of Nemgenix which he established with Michael Jones in 2007.  He is an experienced business executive and lawyer with 21 years commercial experience in the life science sector.  Prior to co-founding Nemgenix Sean was Chief Operating Officer of the UK biotechnology company Inpharmatica Ltd for 7 years (now part of Galapagos NV).  During that time Sean helped raise £55m of equity investment from Europe’s leading venture capital firms.  Previous positions include General Counsel to the (NHS) government research centre at Porton Down, UK, and Head of Legal Affairs at the technology transfer arm of the UK charity 'Cancer Research UK'.  This role encompassed commercialisation of the charity’s $100m+ pa research-spend.  Sean qualified as a solicitor with international law firm Clifford Chance and went on to specialise in commercial and intellectual property law in private practice. He holds graduate degrees in Veterinary Biology and also Genetics and has a Ph.D in plant molecular biology from Cambridge University.  Sean is a Scientific Fellow of the London Zoological Society.

T: +44 (0) 7436 809 823
E:

Mike Jones

Michael Jones

Ph.D

Chief Scientific Officer

Together with Sean Hird, Michael Jones co-founded NemGenix in 2007. Michael is a world expert in the field of plant parasitic nematodes and virology and manages the company’s R&D programmes. He is also the Director of the Western Australian State Agricultural Biotechnology Centre and a Professor of Agricultural Biotechnology at Murdoch University in Australia where he leads the Plant Biotechnology Research Group. Following a first degree and Ph.D in plant biochemistry at Cambridge University, Mike has gone on to produce 230 peer-reviewed publications and 2 books. Before taking up his current position at Murdoch University, Mike managed the cereal transformation programme at Rothamsted Research, UK, for 8 years.

T: +61 (0) 8 9360 2424
E: